Real-World Comparative Effectiveness of Exenatide Once Weekly and Liraglutide in Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Saunders, William
Nguyen, Hiep
Kalsekar, Iftekhar
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1192-P
引用
收藏
页码：A310 / A310
页数：1
相关论文
共 50 条
  • [1] Real-world comparative effectiveness of exenatide once weekly and liraglutide in patients with type 2 diabetes mellitus
    Saunders, W.
    Nguyen, H. Hiep
    Kalsekar, I.
    [J]. DIABETOLOGIA, 2014, 57 : S335 - S336
  • [2] Comparative glycaemic effectiveness of dulaglutide vs liraglutide and exenatide once weekly in a US real-world setting
    Mody, R.
    Huang, Q.
    Yu, M.
    Patel, H.
    Zhao, R.
    Grabner, M.
    Lando, L. Fernandez
    [J]. DIABETOLOGIA, 2018, 61 : S363 - S363
  • [3] Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
    Saunders, William B.
    Nguyen, Hiep
    Kalsekar, Iftekhar
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGET & THERAPY, 2016, 9 : 217 - 223
  • [4] Exenatide once weekly in type 2 diabetes mellitus
    Bischoff, Lindsay A.
    Jabbour, Serge A.
    Miller, Jeffrey L.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (08) : 1297 - 1303
  • [5] Cost Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes Mellitus in Greece
    Tzanetakos, Charalampos
    Bargiota, Alexandra
    Kourlaba, Georgia
    Gourzoulidis, George
    Maniadakis, Nikos
    [J]. CLINICAL DRUG INVESTIGATION, 2018, 38 (01) : 67 - 77
  • [6] Cost Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes Mellitus in Greece
    Charalampos Tzanetakos
    Alexandra Bargiota
    Georgia Kourlaba
    George Gourzoulidis
    Nikos Maniadakis
    [J]. Clinical Drug Investigation, 2018, 38 : 67 - 77
  • [7] Real-World Adherence in Patients Aged=65 years with Type 2 Diabetes Mellitus for Exenatide QW, Liraglutide QD, and Exenatide BID
    Dufour, Robert
    Nguyen, Hiep
    Tarr, Amanda
    Bullano, Michael
    [J]. DIABETES, 2015, 64 : A294 - A295
  • [8] Predictors of Glycemic and Weight Response to Exenatide Once-Weekly in Patients with Type 2 Diabetes in a Real-World Setting
    Gorgojo-Martinez, Juan J.
    Brito-Sanfiel, Miguel A.
    Gargallo-Fernandez, Manuel A.
    Lisbona-Catalan, Arturo
    [J]. DIABETES, 2017, 66 : A297 - A297
  • [9] Exenatide Once Weekly: Effectiveness, Tolerability, and Discontinuation Predictors in a Real-world Setting
    Di Dalmazi, Giulia
    Coluzzi, Sara
    Baldassarre, Maria P. A.
    Sorbo, Sofia Elena
    Dell'Aquila, Stefania
    Febo, Fabrizio
    Ginestra, Federica
    Graziano, Giusi
    Rossi, Maria C.
    Consoli, Agostino
    Formoso, Gloria
    [J]. CLINICAL THERAPEUTICS, 2020, 42 (09) : 1738 - +
  • [10] REAL-WORLD ADHERENCE IN MEDICARE PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) FOR EXENATIDE QW AND LIRAGLUTIDE QD
    Tarr, A.
    Nguyen, H.
    Dufour, R.
    Bullano, M.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A57 - A57
12345